Here to Stay

1st May 2020 By: Terence Creamer - Creamer Media Editor

Here to Stay

During a recent interview with Stephen Sackur, the presenter of BBC HARDtalk, World Health Organisation special envoy for Covid-19 Dr David Nabarro made it painfully clear that humanity will be living with the Covid-19 pandemic for many months to come, if not years. In response to Sackur’s question about how long the world will continue to have to live with the threat of infection, Naborro responded bluntly: “This virus, we think, is not going to go away. Period!”

Unless and until a treatment and/or a vaccine is discovered (and there are many positive developments on that front) countries, cities and communities will have to find ways to live, work, learn and interact while mitigating the risk of infection and the rate at which the virus spreads. Nabarro said there were already examples emerging that pointed to the possibility of transitioning from lockdowns, by putting in place defences against the uncontrolled spread of Covid-19. Such defences would necessarily include clear protocols for how to react if there are new waves of outbreaks.

As with lockdown rules, there will no doubt be significant differences and similarities in the way countries seek to respond to the Covid-19 threat during the post-lockdown phase. For South Africa, this transition is already well under way, with several industries having resumed business, albeit not business as usual.

What is critical as we enter this new phase is not to become fatalistic about the disease, but rather to intensify our collective activism in new ways. Our post-lockdown behaviour will be the key determinant of whether or not the Covid-19 reproduction rate rises exponentially, or whether it remains below a threshold where our healthcare system can continue to respond effectively.

South Africans would be making a grave error should we adopt a fatalistic stance that assumes the only way to beat the virus is to build herd immunity. If we do take up such a position, the rate of infection is likely to surge at a pace and scale that will break our healthcare defences.

It would surely be far more prudent to become activists instead – ones who are determined to keep infection rates low so as to ensure those in need of critical care can receive it, as well as to create more space and time for the discovery of a remedy.

The twin objectives, therefore, should be lower infection rates, but higher economic and learning rates. Achieving such seemingly contradictory goals is likely to mean that business and learning will have to take place under very different conditions so as to facilitate ongoing physical distancing while supporting an intensification of tracing and testing.

To be sure, this next phase will require even more discipline and social cohesion than was shown by most citizens during the March/April lockdown.